In this study, we describe a simple system in which human keratinocytes can be redirected to an alternative differentiation pathway. We transiently transfected freshly isolated human skin keratinocytes with the single transcription factor OCT4. Within 2 days these cells displayed expression of endogenous embryonic genes and showed reduced genomic methylation. More importantly, these cells could be specifically converted into neuronal and contractile mesenchymal cell types. Redirected differentiation was confirmed by expression of neuronal and mesenchymal cell mRNA and protein, and through a functional assay in which the newly differentiated mesenchymal cells contracted collagen gels as efficiently as authentic myofibroblasts. Thus, to generate patient-specific cells for therapeutic purposes, it may not be necessary to completely reprogram somatic cells into induced pluripotent stem cells before altering their differentiation and grafting them into new tissues.
INTRODUCTION
In June 2006, Yamanaka 1 reported that mouse embryonic fibroblasts could be reprogrammed into embryonic stem-like cells by retroviralmediated transduction of four transcription factors, Oct4, Sox2, c-Myc and Klf4. These induced pluripotent stem (iPS) cells proved that differentiated, perhaps nondividing cells, could be reprogrammed into highly proliferative embryonic cells. Since then, a multitude of reports have surfaced showing that iPS cells can be produced from a variety of mouse and human cells. 2, 3 In a proof-of-principle experiment, mouse iPS cells were used in therapy for a sickle cell gene defect in mice, 4 thereby demonstrating their great therapeutic potential. They have also been used to make patient-specific cell lines for human studies. 5 However, the iPS method, which completely reprograms the cells, cannot be used to produce cells for human therapy. Integrating retroviruses or lentiviruses were used to deliver the reprogramming factors. These viruses may cause several problems, including cancer if the integration sites affect oncogenes or tumor suppressor genes. The number of integration sites in the transduced fibroblasts was as high as 20 per clone, resulting in tumor formation in iPS cell-derived mice. 3, 6 Furthermore, this complete reprogramming approach requires the delivery of multiple genes, thus, enhancing the possibility of deleterious effects. Although several groups since 2007 have now shown that iPS cells can be generated without the use of viral vectors and with fewer factors, 7, 8 this technology still exhibits inefficient induction and a long production time, both major limitations if iPS cells are to be used for human therapy.
Skin keratinocytes offer advantages over other cell types for reprogramming. The skin is the largest organ in the body, and the epidermis provides the greatest number of easily obtainable proliferative cells. Moreover, keratinocytes are 100-fold more efficient than fibroblasts when used in the various iPS cell protocols. 9 In addition, our laboratory has shown that mouse epidermal stem cells, a subset of keratinocytes, can populate tissues derived from all three germ layers when injected into the developing blastocyst. 10 Thus, keratinocytes offer high reprogramming and therapeutic potential. Another advantage of keratinocytes is that they are readily obtained from human skin. A recent review emphasized that signaling in the reprogrammed cells varies greatly amongst species. 11 Thus, it is critical to test reprogramming in human cells whether human tissues are to be replaced. Additionally, if patient-specific cells are needed, then rapid cell production may also be critical.
Keeping these two points in mind, we explored the possibility that it might not be necessary to completely reprogram human cells to iPS cells to use them to replace damaged human tissues. In this study, we tested the potential of using freshly isolated human skin keratinocytes (HSKs) for rapid alternative tissue replacement. We transiently transfected keratinocytes with the human OCT4 transcript, exposed these cells to alternative differentiating conditions and tested the functionality of these new cell types. The results presented in this study demonstrate that a transient exposure to OCT4 is sufficient to effect changes that allow directed differentiation of the human keratinocytes into functioning mesodermally derived cell types. This method could be used to provide customized patient-specific cells for therapeutic purposes.
RESULTS

OCT4 protein is temporally expressed in human keratinocytes
To demonstrate that a transient exposure to OCT4 is sufficient to allow a change in differentiation of the human keratinocytes, we needed to show that the OCT4 transcription factor was expressed for a short amount of time, and when expressed, it moved to the nucleus in which it could transactivate its target genes. We transiently introduced a plasmid carrying the full-length human OCT4 transcript into human keratinocytes and determined where and for how long the OCT4 protein was expressed. Using immunocytochemical analysis, we determined that the OCT4 protein localized to the nuclei of the transfected keratinocytes 48 h after transfection (Figure 1b) . Untransfected control keratinocytes showed no expression of OCT4 (Figure 1a) . To investigate the temporal expression pattern, we counted the numbers of OCT4-expressing keratinocytes over 6 days (Figure 1c) . At 24 h after transfection, B24% of cells expressed OCT4. This percentage peaked at 48 h with B32% of cells expressing OCT4. With each day thereafter, the percentage of keratinocytes expressing OCT4 decreased with most lost by 6 days post transfection. Thus, pcDNA3-OCT4 transiently produced the OCT4 protein that localized to the nuclei of the keratinocytes.
Transfected cells show transient expression of endogenous OCT4 target genes
As the OCT4 protein translocated to the nucleus, we hypothesized that the keratinocytes would show transient reactivation of some of the endogenous OCT4 targets. Using RT-PCR, we investigated expression of SOX2, NANOG and REX-1 in the transiently transfected keratinocytes ( Figure 2 ). The OCT4 primers detected the OCT4 transcript from either the plasmid or the endogenous gene for 5 days after transfection. This correlated with the protein expression pattern described above (Figure 1c ). We found a temporal expression pattern of endogenous OCT4 target genes. SOX2 expression was clearly evident on days 1 and 2 after OCT4 transfection, with less expression on the following days. NANOG was expressed for as long as OCT4 was expressed. REX-1, on the other hand, was not detected until day 3 after transfection, which is not so surprising as it is normally activated only in the presence of both OCT4 and SOX2. Keratinocytes transfected with the control pcDNA3-green fluorescent protein (GFP) plasmid or untransfected keratinocytes showed no expression of these genes ( Figure 2 , bottom gel). Moreover, once the cells transiently transfected with OCT4 were induced to differentiate (see experiments described below), neither OCT4 nor its target genes were detectable.
Transient expression of OCT4 alters methylation states of OCT4 and NANOG promoters Although demethylation of the promoter region of the OCT4 gene has been shown in iPS cells, 12 the methylation state of the endogenous OCT4 promoter after transient transfection has not been reported. Thus, we sequenced bisulfite-treated genomic DNA from the human keratinocytes that had been transiently transfected with pcDNA3-OCT4. We ensured that OCT4-transfected cells only were examined by using a fusion product of OCT4 and GFP, which we inserted into the pcDNA3 vector. This allowed us to use fluorescence-activated cell Transient expression of OCT4 D Racila et al sorting to sort the transfected from the untransfected cells by sorting for GFP positive cells. We analyzed human keratinocytes transfected for 48 h with pcDNA3-OCT-GFP or with the control plasmid pcDNA3-GFP. As a hypomethylated control, we used the NTERA-2 cell line. The OCT4 promoter region of the NTERA-2 cells was mostly demethylated (Figure 3 ). This was expected as NTERA-2 cells are embryonic in character and the OCT4 gene is continually expressed. Both the human keratinocytes transfected with GFP alone or with OCT4-GFP showed greater methylation as compared with the NTERA-2 cells. However, the OCT4-transfected keratinocytes showed a consistent demethylation of two cytosines (positions 74 and 80). We confirmed that the OCT4-GFP was effecting endogenous changes by examining the methylation state of NANOG, which is an embryonic pluripotent gene and importantly, a gene that was not exogenously introduced into the human keratinocytes. At 48 h after transient transfection with OCT4-GFP, the NANOG gene also showed partial and consistent demethylation at positions À649, À611, À565, À516 and À378 upstream of the translational start site (Figure 3 ). This is consistent with our finding for the endogenous OCT4 promoter and corresponds to published demethylated areas in fully-converted iPS cells. 13 Thus, transient expression of OCT4 results in partial demethylation of the endogenous OCT4 and NANOG promoters.
Transient expression of OCT4 effects a decrease in global genomic methylation Global changes in DNA methylation patterns throughout the genome occur when a cell's differentiation or developmental state is changed. However, it was not known whether transient expression of OCT4 could alter the overall level of DNA methylation. Using a modified enzyme-linked immunosorbent assay, we investigated the global methylation level of human keratinocytes transiently transfected with OCT4. Controls were GFP-transfected keratinocytes, untransfected keratinocytes and the undifferentiated NTERA-2 cells. Examining the control cells, we found that global methylation levels between untransfected keratinocytes and GFP-transfected keratinocytes were not significantly different, whereas methylation states between GFPtransfected keratinocytes and NTERA-2 cells were significantly different ( Figure 4 ). Keratinocytes transiently expressing the OCT4-GFP fusion protein showed a significant decrease in global methylation as compared with untransfected and GFP-transfected keratinocytes. The OCT4-transfected cells exhibited a methylation level as low as that found in the NTERA-2 cells (Figure 4) . Thus, transient transfection of OCT4 causes a generalized demethylation of the DNA in keratinocytes, suggesting an overall reprogramming in the keratinocytes that might make them susceptible to a directed change in their differentiation pathway.
Transient expression of OCT4 allows differentiation of human keratinocytes into human neuronal-like cells Encouraged by the changes in global methylation of the transiently transfected human keratinocytes, we assessed the susceptibility of these cells to be redirected into a neuronal differentiation pathway. We transfected HSKs with pcDNA3-OCT4, and at 48 h switched their media to one of two types of neuronal differentiation media. Medium #1 was specifically modified for human cells from a mouse protocol. 14 Medium #2 contained Noggin and SB-431542, inhibitors of the type I transforming growth factor-b receptor, shown to block phosphorylation and nuclear translocation of Sma and Mad related proteins (SMADs) and to promote differentiation of embryonic stem cells and iPS cells into dopaminergic neurons. 15 Controls for these experiments were untransfected human keratinocytes grown in the keratinocyte medium (KSFM), untransfected keratinocytes grown in one of the neuronal media and a neuroepithelioma cell line (SK-N-MC). At the time of switching the media, all cells exhibited the typical cobblestone shape found in proliferating keratinocyte cultures. At 12 days later, the keratinocytes transiently transfected with OCT4, and the untransfected keratinocytes kept in KSFM still resembled proliferative keratinocytes ( Figure 5a ). The untransfected keratinocytes switched to either neuronal media #1 or #2 became large, flat cells that lifted off the dish (data not shown). This was likely because of the neuronal media containing high calcium levels, which is known to halt proliferation and induce terminal differentiation of skin keratinocytes. 16 In contrast, keratinocytes that had been transfected with pcDNA3-OCT4 48 h before switching to the neuronal media exhibited neuronal phenotypic changes. These cells no longer showed the typical keratinocyte cobblestone appearance, but instead formed tight clusters of elongated cells, with triangular cell bodies and lengthy projections ( Figure 5b ).
To confirm that a change from keratinocyte to neuronal cell type had occurred, we examined the cultures for loss of keratin 14 (K14), We also probed for a concomitant expression of the following neuronal markers: Tuj1, the neural progenitor marker bIII tubulin; NeuN, the neuronal nuclear Fox-3 splicing protein found in cultured neurons; and tyrosine hydroxylase, the rate limiting enzyme in dopaminergic neurons. RNA and protein were collected from cultures 12 and 22 days after switching the media. RT-PCR revealed that the transiently transfected cells that were differentiated in medium #1 expressed NeuN, Tuj1 and tyrosine hydroxylase, whereas the same cells grown in medium #2 expressed Tuj1 and tyrosine hydroxylase, but no NeuN (Figure 5c ), suggesting that two different types of neuronal cells were produced. These cultures also showed very light expression of K14, indicating that some keratinocytes were present. This was not totally unexpected, as we had not achieved 100% transfection efficiency ( Figure 1 ). Untransfected control keratinocytes expressed K14, but did not express any of neuronal markers, whether grown in KSFM or either of the neuronal media ( Figure 5c ). The neuroepithelioma cell line expressed Tuj1 and no K14. Western blot analysis for NeuN supported the RT-PCR results ( Figure 5d ). The phenotypic changes, as well as the changes in gene and protein expression, were consistent and repeatable, suggesting that a 48-h transient expression of OCT4 is sufficient to render human keratinocytes susceptible to changing their differentiation pathway into cells derived from the neuroectoderm.
Human keratinocytes can be redirected into human mesenchymal cells To determine that transient transfection of OCT4 is sufficient to allow redirection of keratinocytes into mesodermally derived cell types, we modified a published protocol used to differentiate multipotent progenitor cells into smooth muscle cells. 17 At 48 h after transfection with pcDNA3-OCT4, human keratinocytes were transferred into the mesenchymal differentiation medium containing transforming growth factor-b1, PDGF-BB and 100 mM ascorbic acid (AA). After 4 days in this medium, the transfected keratinocytes began to change their phenotype. By 12 days, none of the cells exhibited the typical cobblestone shape of keratinocytes. Instead they were all elongated rod-shaped cells, with parallel orientation and typical characteristics of Figure 3 Transient expression of OCT4 produces a change in methylation state of the endogenous OCT4 and NANOG promoters in the transfected human skin keratinocytes (HSK-OCT4-GFP). Shown are methylation states of CpG islands from À929 to +421 around the transcription start site of the endogenous OCT4 promoter and upstream areas À1091 to À299 of the NANOG promoter for the NTERA-2 cell line (positive control), human skin keratinocytes (HSK-GFP) 48 h after transient transfection with pcDNA3-GFP (negative control) and human skin keratinocytes (HSK-OCT4-GFP) at 48 h after transient transfection with pcDNA3-OCT4-GFP. Transfected keratinocytes were sorted from untransfected keratinocytes based on GFP; thus the analysis was done only on the transfected cells. Note, demethylation of OCT4 was consistent at +74 and +80, and demethylation of NANOG was consistent at À649, À611, À565, À516 and À378. Numbers are relative to translational start site. (Figure 6b ). The untransfected keratinocytes grown in KSFM for 12 days retained their keratinocyte morphology (Figure 6a ). However, if grown in the mesenchymal medium, these cells terminally differentiated because of the high level of calcium in the medium. 16 In general, both the RT-PCR (lane 1 in Figure 6d ) and the western blot analysis (lane 1 in Figure 6e ) confirmed that the cells exhibited a mesenchymal phenotypic change. No K14 was found in the keratinocytes transfected with OCT4 and grown in the mesenchymal medium for 12 days, suggesting that no keratinocytes remained in these cultures (lane 1 Figures 6d and e) . Both the untransfected keratinocytes and the keratinocytes transfected with OCT4 and grown in KSFM expressed K14, but did not express any of the mesenchymal markers (lanes 2 and 3 in Figures 6d and e) . Taken together, the changes seen in phenotype, gene expression and protein expression suggest that transient transfection with OCT4 is sufficient to allow keratinocytes to be differentiated into mesenchymal cells.
Mesenchymal cells differentiated from keratinocytes transiently transfected with OCT4 function as contractile cells
To further assess the mesenchymal cells, we used a classic contraction assay to determine if they could function as contractile cells. Keratinocytes were transfected with pcDNA3-OCT4 for 48 h, then grown in the mesenchymal medium for 10 days. After this, the cells were removed from the culture dish and embedded in collagen type I gels. Control cells were: untransfected keratinocytes grown in mesenchymal medium or KSFM, primary human fibroblasts and the WPMY-1 myofibroblast cell line. Function was assessed by determining how well the cells contracted the gel. The amount of contraction was determined by measuring the diameters of the collagen disks over time. The OCT4-transfected keratinocytes grown in the mesenchymal medium contracted the collagen type I gels at a rate similar to the freshly isolated dermal fibroblasts (2.3 vs 2.2 mm per day) and slightly more rapidly than the WPMY-1 myofibroblast cell line (1.7 mm per day) (nos. 1, 4 and 5 in Figure 7a ). There was no significant difference in the total amount of contraction (B50%) among these three cell types (Figure 7b ). The untransfected keratinocytes whether grown in KSFM or in the mesenchymal medium did not contract the collagen gels at all (lanes 2 and 3 in Figure 7a ). Thus, transient transfection of OCT4 is sufficient and necessary to allow HSKs to be differentiated into functioning alternative cell types.
DISCUSSION
In 1990, OCT4 was discovered to be a transcription factor that was essential for mammalian early embryonic development. 19, 20 Since then, OCT4 has been proved necessary to maintain pluripotency of embryonic stem cells in which it activates other pluripotency genes and represses differentiation genes. 21 Thus, OCT4 is considered to be the master regulator of pluripotency. Two genes that OCT4 activates are Sox2 and NANOG. Along with OCT4, these genes are required to Transient expression of OCT4 D Racila et al maintain cells in the pluripotent state. 22, 23 However, for the pluripotent cells to differentiate, all three of these genes must be turned off. 24, 25 Thus, we reasoned that, to increase the potential of somatic cells, OCT4 would first need to be introduced into the cells, maintained just long enough to reactivate the endogenous Sox2 and NANOG genes then all three genes would have to be turned off in the cells to redirect the cell's differentiation into an alternative cell type. Very recently, it was shown that each species' cells react differently to reprogramming and differentiation signals, such that it is imperative that the correct species cells be used to obtain the correct subsequent differentiation signals. 11 As we hoped to develop a technology that could be translated to human therapy, we transiently expressed the human OCT4 cDNA in freshly isolated HSKs. This resulted in reactivation of the endogenous SOX2 and NANOG genes in the cells, but only for 4 to 5 days. We discovered that if these cells were exposed to new growth factors and cytokines during this 4-day period, they could be stimulated to change their differentiation pathway. Furthermore, we could define the type of new cell by exposing the transiently transfected keratinocytes to specific differentiation factors designed for specific cell types. This strategy allowed us to direct the keratinocytes to differentiate into dopaminergic neurons, which expressed tyrosine hydroxylase, and into mesenchymal cells, which showed contractile function. Thus, this simple technology could allow rapid development of replacement cells for human therapy. Recently, much emphasis has been on making iPS cells by fully dedifferentiating somatic cells. In 2006, Takahashi and Yamanaka 1 demonstrated that mouse fibroblasts could be reprogrammed into fully-functional pluripotent stem cells that resembled embryonic stem cells. To do this, they genomically incorporated four factors (OCT4, Sox2, Klf4 and c-myc) into the mouse fibroblasts using retroviral vectors. Although exciting, two limitations preclude this technology from being easily translated to humans: genomic retroviral integration and the very low-induction efficiency to form the functional iPS cells. 5 Even keratinocytes, which were reported to be 100-fold more receptive than fibroblasts, formed iPS cells at a rate of only 0.7%. 9 Varas et al. 26 examined retroviral insertion sites in clones of iPS cells derived from mouse fibroblasts and determined that although there were several insertion sites in numerous genes, none of them were specifically common among the iPS clones. They concluded that the low-induction efficiency could not be explained by insertional mutagenesis of the retroviruses. Thus, it is still unclear why this technology is so inefficient in inducing iPS cells.
More recently, several reports described alternative ways to make iPS cells. Most were designed to result in transgene-free iPS cells that could be used for future therapeutic applications. Sommer et al. 27 described a lentiviral expression vector that carried OCT4, Sox2, Klf4 and c-myc in a single vector with 2A peptide and internal ribosome entry site technology. This system has the advantage over the initial retroviral system by allowing expression of all four factors with a single viral insertion, thereby decreasing the potential of insertional mutagenesis. Yusa et al. 28 used the piggyBac transposon to integrate the four factors into mouse embryonic fibroblasts. This transposon is a mobile element from insects, which integrates into mammalian genomes at TTAA sites. The advantage over viral integration is that the transposon can be removed from the host with little to no change in nucleotide sequences because the integration sites are repaired on excision. 28 Stadtfeld et al. 29 generated iPS cells using a nonintegrating adenoviral vector. In this system, the iPS cells showed the expected characteristic embryonic changes, that is, expression of endogenous pluripotency genes, formation of teratomas and demethylation of DNA. Another system used continual transfection of plasmid vectors carrying the four genes into mouse embryonic fibroblasts. 8 This produced virus-free and functional iPS cells, which was an improvement over the viral vector systems; however, it still took several months to make the iPS cells. Although both the adenoviral transduction and repeated plasmid transfection successfully generated integration-free iPS cells, the efficiency of reprogramming using these methods was 100-1000-fold lower than the retroviral method, thereby reducing induction efficiency to 0.001-0.0001%. As genetic alterations could occur during the reprogramming process, the retroviral and lentiviral systems are problematic for human use. Of the insertional technologies, the piggyBac system offers the best alternative as it allows correction of most of the insertion sites. One concern of this system was shown in mouse embryonic stem cells, where approximately 5% of the excision sites showed microdeletions, which might be mutagenic. 28 It will be critical to maintain genomic stability if we wish to use the cells in humans. The success of the adenoviral system and the multiplasmid transfection confirms that insertional mutagenesis is not a requirement for cellular reprogramming. Our system goes one step further. Instead of reprogramming the somatic cells completely to embryonic stem cells, we show that a transient expression of OCT4 is enough to allow the keratinocytes to change their differentiation pathway.
It is clear that manipulating genetic expression of embryonic pluripotency genes is critical to reprogramming iPS cells. However, it may not be necessary to introduce four exogenous genes into the cells. For example, CD45+ cord blood cells were successfully differentiated into several other cell types by exposing the cells to culture medium containing several growth factors. Such cells showed transient expression of OCT4 and NANOG with concomitant changes in H3 and H4 histone acetylation. 30 This has some limitations as not everyone will have access to cord blood cells. Using skin keratinocytes is a relevant alternative. It may be that keratinocytes are unique among somatic cell types. As keratinocytes are responsive to the external environment and are continually replacing themselves, 31, 32 it may be that they are more readily responsive to partial reprogramming than are fibroblasts. Furthermore, our previously published data demonstrate that mouse epidermal stem cells can be reprogrammed by transferring them into the developing blastocyst, which suggests that keratinocyte stem cells might be amenable to reprogramming without external transfection. 10 It would advantageous if we could directly translate the mouse findings to human keratinocyte stem cells. However, we have been unsuccessful in using the mouse sorting technology that we developed to isolate human keratinocyte stem cells, which suggests that human skin and mouse skin keratinocyte stem cells differ at some as yet unknown fundamental property.
The data presented here suggest that a brief introduction of the single factor OCT4 into HSKs is sufficient to alter the global methylation of the cells. Furthermore, if these cells are then exposed to differentiating factors, they respond by not only changing their phenotype and gene and protein expression profiles but also their function. Thus, our findings suggest that it is not necessary to fully dedifferentiate human keratinocytes into iPS or embryonic stem cells to use them in translational therapies.
MATERIALS AND METHODS
Cell isolation, culture and transfection
Primary adult HSKs and human fibroblasts were isolated from normal skin obtained from the Surgical Pathology Department at The University of Iowa Hospitals and Clinics with full approval of The University of Iowa's IRB. The
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D Racila et al skin specimens were not diseased or pathological; they were from amputations after accidents, mammary reductions or from surgical reductions for obesity. The ages of the donors were noted for each experiment. To ensure sterility, strips of skin were soaked for 1 h in a medium containing 10% antibioticantimycotic (Invitrogen, Carlsbad, CA, USA). Epithelial sheets were mechanically separated from the connective tissue after overnight incubation of skin in Dispase II (24.0 U ml À1 , Roche, Indianapolis, IN, USA) at 4 1C. HSKs were isolated from the epithelial sheets by treatment in 0.25% trypsin (Invitrogen) for 30 min at 37 1C. Cells were plated at a concentration of 8Â10 4 cells ml À1 in keratinocyte serum-free medium (KSFM, Invitrogen)+1.5% antibiotic-antimycotic on culture dishes coated with 0.25 mg cm À2 collagen type IV (Collaborative Biomedical, a division of BD Biosciences, Bedford, MA, USA). Fibroblasts were obtained by treating the connective tissue in 0.4% collagenase for 1 h at 37 1C. Human fibroblasts were plated at a concentration of 8Â10 4 cells ml À1 in Dulbecco's modified Eagle's medium (DMEM)+10% fetal bovine serum+1.5% antibiotic-antimycotic. For transfection, cells were grown as a monolayer culture at 37 1C in a 5% CO 2 humidified incubator until 50-60% confluent, then transiently transfected with pcDNA3-OCT4, pcDNA3-OCT4-GFP or pcDNA3-GFP using Turbofection (OriGene, Rockville, MD, USA) at a concentration of 1 mg of plasmid to 2 ml of Turbofection per cm À2 . The transfection solution was left on the cells for 6-24 h and then replaced with complete medium. Control cell lines, obtained from the ATCC (atcc.org, Manassas, VA, USA) and cultured according to ATCC instructions, were the following: NTERA-2, a human teratocarcinoma cell line with characteristics and gene expression profiles similar to cultured human embryonic cells; WPMY-1, a human myofibroblast cell line with characteristics similar to smooth muscle cells; and SK-N-MC, a neuroepithelioma cell line with characteristics similar to cultured proliferative neuronal cells.
RNA extraction and RT-PCR
Total RNA was extracted from cultured cells using TRIzol or the RNAqueous-4PCR kit (Invitrogen) according to manufacturer's instructions. cDNA was generated through a reverse transcription reaction consisting of the following: 1.5 mg of RNA, 50mM random primers, 5Â FS RT buffer, 10 mM dNTP mix, 0.1 M dithiothreitol, 40 IU RNasin, 200 IU RTase superscript III and nuclease-free diethyl pyrocarbonate water. RNA, random primers, dNTPs and water were combined and heated at 65 1C for 5 min, then chilled on ice. Following addition of the other components, the RT reaction was incubated at 25 1C for 5 min, at 55 1C for 1 h and then at 70 1C for 15 min using a GeneMate Genius (ISC Bioexpress, Kaysville, UT, USA) or a MultiGene (LabNet, Edison, NJ, USA) thermocycler, and then chilled on ice. For PCR, 1 ml of cDNA template was added to 24 ml of the following reaction mixture: 10x PCR buffer; 25 mM MgCl 2 , nuclease-free diethyl pyrocarbonate water, 10 mM dNTPs (Invitrogen), 5 IU Taq polymerase (Qiagen, Valencia, CA, USA) and 10 mM of each primer. PCR was performed for 35 cycles using the following conditions: denaturation at 94 1C for 0.5-2 min, annealing at the specified melting temperature (see below) for 1 min., elongation at 72 1C for 1minkb À1 . Positive controls were RNA isolated from neuroepithelioma SK-N-MC cells or cDNA from aorta (purchased from ScienCell, Carlsbad, CA, USA) (see the below table).
Protein isolation and western blot analysis
Protein was extracted from experimental and control cells by scraping in 0.5 ml RIPA buffer (Thremo Fisher Scientific (Pierce), Rockford, IL, USA) per 100 mm culture dish. After 30 min incubation on ice, the slurry was spun at 13 000 r.p.m., protease inhibitor added (Roche) and the supernatant collected. Protein concentration was determined using the Bradford Assay (Bio-Rad, Hercules, CA, USA). All proteins were detected by western blot with commercially available antibodies. Proteins (20 mg protein per lane) were resolved using 12% polyacrylamide gels (Bio-Rad) and then transferred to pure nitrocellulose membrane (0.045 mM, Bio-Rad) using the semidry transfer Trans Blot-SD system (Bio-Rad). Membranes were washed in TBS/0.1% Tween-20, blocked for 2 h in 5% low-fat milk in TBS/0.1% Tween and incubated with primary antibodies over night at 4 1C on a shaker, then rinsed and incubated with infrared-conjugated secondary antibodies (IRDye800 anti-mouse IgG (1:2500), Rockland Inc., Philadelphia, PA, USA). Protein immunoblots were scanned using the Odyssey, LI-COR-infrared imager (Li-Cor Biosciences, Lincoln, NE, USA). Protein extracted from control cell lines (WPMY-1, SK-N-MC) were similarly treated as that to the experimental cells. Primary antibodies were: mouse anti-NeuN (1:500, Millipore, Billerica, MA, USA), mouse anti-SM22a (1:1000, Abcam, Cambridge, MA, USA), mouse anti-Myocardin (1:1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse anti-Vimentin (1:1000, BD Biosciences, San Jose, CA, USA) and mouse anti-Actin (1:1000, Sigma-Aldrich, St Louis, MO, USA).
Fluorescence-activated cell sorting
Cells were transiently transfected with pcDNA3-OCT4-GFP or pcDNA3-GFP, collected at 48 h using 0.5% trypsin/EDTA, pelleted by centrifugation and resuspended at 2Â10 6 cells ml À1 in phosphate-buffered saline. Propidium iodide was added to a final concentration of 0.1 mg ml À1 and the cells were filtered through a 70 mm cell strainer before sorting. Cells were live sorted using a FacsDiva in the University of Iowa's Flow Cytometry Core Facility. Transiently transfected live cells were selected by negative staining of propidium iodide and positive staining for GFP. For experiments measuring DNA methylation, cells were lysed and genomic DNA collected following the spin-column protocol (DNeasy Blood and Tissue kit, Qiagen).
Global DNA methylation
Global DNA methylation was measured with a modified enzyme-linked immunosorbent assay using the Methylamp Global DNA Methylation kit (Epigentek, Brooklyn, NY, USA) according to the manufacturer's protocol. Replicate samples of genomic DNA were bound in 96-well strip wells. Samples were blocked, and then labeled using an anti-methyl-cytosine primary antibody and an enzyme-conjugated secondary antibody. Following addition of the substrate solution for 2 to 5 min, the reaction was halted and absorbance at 450 nm was measured. To quantitate DNA methylation, samples were background subtracted and normalized to 100% methylated DNA control samples.
Forward primer
Reverse primer  Tm  bp   hOCT4  CAGTGCCCGAAACCCACAC  GGAGACCCAGCAGCCTCAAA  59  161  hSOX2  CAGGAGTTGTCAAGGCAGAGAAGA  GCCGCCGCCGATGATTGTTATTAT  60  320   hNANOG  TTTGGAAGCTGCTGGGGAAG  GATGGGAGGAGGGGAGAGGA  59  194  hREX-1  CAGATCCTAAACAGCTCGCAGAAT  GCGTACGCAAATTAAAGTCCAGA  56  310   hNeuN  AGCGACAGTTACGGCAGAGT  ACTTGGACTTGGTTGGATGC  57  235  Tuj1  GGCCAAGTTCTGGGAAGTCA  CGAGTCGCCCACGTAGTTG  57  235   TH  TTGCTGAGATCGCCTTCCAGTACA  AGTACAGCGTGGACAGCTTCTCAA  60  495  Calponin  AGGCTCCGTGAAGAAGATCA  CCACGTTCACCTTGTTTCCT  55  214   SM22a  CGCGAAGTGCAGTCCAAAATCG  GGGCTGGTTCTTCTTCAATGGGG  59  906  K14  TTCTGAACGAGATGCGTGAC  GCAGCTCAATCTCCAGGTTC  59  188   GAPDH  GAAGGTGAAGGTCGGAGTC  GAAGATGGTGATGGGATTTC  55  226 Transient expression of OCT4 D Racila et al
Site-specific DNA methylation determination
Bisulfite sequencing was used to measure the methylation of specific sites surrounding the promoter region of OCT4. Nonmethylated cytosines were converted to uracils by a two-step chemical/bisulfite reaction using (EZDNA methylation kit, Zymo Research, Orange, CA, USA). The region surrounding the OCT4 start site of the converted DNA was PCR amplified using three sets of primers covering the range from À910 to 535 (numbers relative to translational start site). For NANOG, region À1091 to À299 was PCR amplified. Primers for OCT4 and NANOG were the following sets:
Cloning of PCR products was done using TOPO TA Cloning kit (Invitrogen). PCR products were legated into pCR2.1-TOPO, and used to transform DH5a competent cells following the manufacturer's protocol. Transformed cells were spread on selective agar plates containing 50 mg ml À1 ampicillin, spread with 40 ml of 40 mg ml À1 X-gal and incubated at 37 1C overnight. White colonies were picked, grown at 37 1C overnight in LB medium containing 50 mg ml À1 ampicillin. Plasmid DNA from each sample was collected and purified using the PureLink Quick Plasmid Miniprep Kit (Invitrogen) following the manufacturer's instructions. Plasmid preparations were tested for the presence of the inserted PCR product by restriction enzyme analysis using EcoR1. All positive preparations were sequenced at the University of Iowa DNA facility using the M13 reverse primer in pCR2.1-TOPO.
Neuronal cell differentiation
The HSKs were plated and transiently transfected with pcDNA3-OCT4 as described above. At 48 h later, the cells were exposed to neuronal medium using one of two protocols. Conditions for Protocol #1 (for general neural differentiation) were modified for human cells from the procedure of Grinnell et al., 14 which was based on the procedure from Jiang et al. 33 The base medium consisted of 60 ml DMEM-low glucose (Invitrogen), 40 ml MCDB-201 (Sigma), 1 ml insulin-transferrin-selenium (Sigma), 1 ml linoleic acid-albumin (Sigma), 3 mg AA 2-phosphate (Sigma), 1 ml 100 mM dexamethasone (Sigma) and 1 ml antibiotic-antimycotic (Invitrogen). This combination was stirred, filter sterilized and then frozen into aliquots at 20 1C. The base medium was supplemented with 100 ng ml À1 basic fibroblast growth factor (Sigma), 100 ng ml À1 sonic hedgehog (SHH, Sigma), 10 ng ml À1 fibroblast growth factor-8 (Cell Sciences, Canton, MA, USA) and 10 ng ml À1 brain-derived neurotrophic factor (Cell Sciences). Cells were then cultured for 22 days, with the medium renewed every second day. Cells were photographed every 2 days. On day 22, RNA and protein were extracted for RT-PCR and western blot, respectively.
Conditions for Protocol #2 (for dopaminergic neuron differentiation) were modified from Chambers et al. 15 Neuronal differentiation of transfected HSKs was initiated by adding KSR medium containing 10 mM SB431542 (Tocris, Ellisville, MO, USA), an inhibitor of SMAD phosphorylation, and 500 ng ml À1 Noggin (R&D systems, Minneapolis, MN, USA). The combination of these two molecules inhibited SMAD signaling and promoted neuronal differentiation. 15 The KSR medium consisted of 820 ml of knockout DMEM (Invitrogen), 15% KSR serum (Invitrogen), 1% L-glutamine 200 mM (Invitrogen), 1% antibioticantimycotic (Invitrogen) 1% MEM NEAA (Invitrogen) and 1 ml of 2-mercaptoethanol (Sigma). On day 3 of differentiation, the KSR was replaced with fresh KSR containing SB431542 and Noggin. On day 5, KSR was replaced with a 3:1 mixture of KSR/N2 (Invitrogen) media containing 10 mM SB431542, 500 ng ml À1 Noggin and 200 ng ml À1 SHH (Sigma). On day 7, the medium was replaced with KSR/N2 media 1:1 containing SB431542, Noggin and SHH. On day 9, the medium was replaced with KSR/N2 media 1:3 containing SB431542, Noggin, SHH and 100 ng ml À1 fibroblast growth factor-8 (Cell Sciences), 20 ng ml À1 brain-derived neurotrophic factor (Cell Sciences) and 0.2 mM AA (Sigma). On day 11, the medium was replaced with N2 media containing SB431542, Noggin, SHH, fibroblast growth factor-8, brain-derived neurotrophic factor and AA. On day 12, addition of Noggin and SB431542 was ceased. Thereafter, the medium was replaced every 2 days with N2 media containing 20 ng ml À1 brain-derived neurotrophic factor, 10-20 ng ml À1 glial cell line-derived neurotrophic factor and 0.2 mM AA, 0.5-1.0 mM dibutyryl camp, 1 ng ml À1 transforming growth factor type b3 (R&D Systems). Cells were photographed every 2 days. RNA and protein were extracted for RT-PCR and western blot, respectively, on day 12.
Contractile mesenchymal cell differentiation
HSKs were plated and transfected with pcDNA3-OCT4 as described above. At 48 h after transfection, medium was replaced with smooth muscle medium containing: DMEM with 10% FBS (Thermo Scientific HyClone, Logan, UT, USA), 2.5 ng ml À1 TGF-b1 (R&D Systems), 5 ng ml À1 PDGF-BB (R&D Systems) and 100 mM AA (Sigma). The medium and protocol was modified from Ross et al. 17 Cells were photographed and medium was changed every 2 days for 12 days. On day 12, RNA and protein were extracted for RT-PCR and western blot, respectively.
Contraction of collagen type I gels
To test function, cells were added to collagen gels and rates of contraction determined. Gels were made as follows: DMEM (high glucose, Invitrogen) + 10% fetal bovine serum with 7Â10 4 cells added to rat-tail collagen type I (BD Biosciences) to make a concentration of 1.25 mg ml À1 . The pH was raised to neutral with 0.1 N NaOH. Cells and collagen were allowed to gel at room temperature for 15 min in 12-well culture plates, then 1 ml of DMEM+10% fetal bovine serum + fresh vitamin-C (50 mg ml À1 ) was added. A sterile pipette tip was passed around the solidified collagen in the well to detach the collagen disk from the culture dish and allow it to float unimpeded, and the plates were placed in a 37 1C in 5% CO 2 incubator. Medium was replaced each day. Experimental and control cells were plated in triplicate and the diameter of each collagen disk was photographed and measured every day for 4 days. Mean diameters were calculated and s.d.'s were determined. Results were graphed. 
